Evaluation of Total Bilirubin Determination in Neonatal Whole-Blood Samples by Multiwavelength Photometry on the Roche OMNI S Point-of-Care Analyzer

Boris Rolinski, Anthony Okorodudu, Gerald Kost, Markus Roser, Jiaxi Wu, Ada Goerlach-Graw, Helmut Kuester

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Jaundice is a common finding in healthy and diseased neonates. Because of early discharge, the risk of kernicterus is a re-emerging problem in the United States. Precise and accurate determination of plasma total bilirubin concentrations is the indispensable prerequisite for proper management of jaundiced infants. In this multicenter study, we investigated the analytical performance of the Roche OMNI S blood gas analyzer for measurement of total bilirubin from neonatal whole blood using a multiple-wavelength photometric method. The results were evaluated relative to simultaneously obtained results from routine clinical chemistry methods and one other point-of-care testing device. A total of 496 heparinized blood samples were drawn from newborns (≤39 days of age). An aliquot of the whole-blood sample was measured on Roche OMNI S and on the Radiometer ABL 735. Plasma was prepared from the remaining sample for laboratory analysis. Total bilirubin was measured on the LX20 (Beckman Coulter), Hitachi 912 and 717 (Roche Diagnostics), Dimension (Dade Behring), and Vitros 250 (Ortho Clinical Diagnostics). Plasma bilirubin concentrations covered the diagnostic relevant range up to 23.7 mg/dL. Overall, there was a good agreement between the bilirubin concentrations measured in whole blood on Roche OMNI S and Radiometer ABL 735 and between the comparison routine analyzers. Correlation coefficients were all above 0.94, and the slope of the regression lines ranged from 0.971 to 1.172. The mean biases ranged from -0.3 to 1.4 mg/dL, and the differences between comparison methods were less than those reported in proficiency testing. Direct spectrophotometric measurement of bilirubin in neonatal whole-blood samples gives results that compare well with those obtained using routine clinical chemistry methods. Its advantages are the very small volume of blood and the short turn-around time. Thus, the Roche OMNI S analyzer represents a suitable method for monitoring neonatal jaundice at the point of care.

Original languageEnglish (US)
Pages (from-to)3-8
Number of pages6
JournalPlastic Surgical Nursing
Volume4
Issue number1
DOIs
StatePublished - 2004

Fingerprint

Point-of-Care Systems
Photometry
Bilirubin
Clinical Chemistry
Jaundice
Kernicterus
Newborn Infant
Neonatal Jaundice
Blood Volume
Multicenter Studies
Gases
Equipment and Supplies

Keywords

  • analysis
  • bilirubin
  • determination
  • multiwavelength photometry
  • neonate
  • point-of-care testing
  • whole blood

ASJC Scopus subject areas

  • Surgery
  • Medical–Surgical
  • Advanced and Specialized Nursing

Cite this

Evaluation of Total Bilirubin Determination in Neonatal Whole-Blood Samples by Multiwavelength Photometry on the Roche OMNI S Point-of-Care Analyzer. / Rolinski, Boris; Okorodudu, Anthony; Kost, Gerald; Roser, Markus; Wu, Jiaxi; Goerlach-Graw, Ada; Kuester, Helmut.

In: Plastic Surgical Nursing, Vol. 4, No. 1, 2004, p. 3-8.

Research output: Contribution to journalArticle

Rolinski, Boris ; Okorodudu, Anthony ; Kost, Gerald ; Roser, Markus ; Wu, Jiaxi ; Goerlach-Graw, Ada ; Kuester, Helmut. / Evaluation of Total Bilirubin Determination in Neonatal Whole-Blood Samples by Multiwavelength Photometry on the Roche OMNI S Point-of-Care Analyzer. In: Plastic Surgical Nursing. 2004 ; Vol. 4, No. 1. pp. 3-8.
@article{49e47abe320249818972575b28cb03e6,
title = "Evaluation of Total Bilirubin Determination in Neonatal Whole-Blood Samples by Multiwavelength Photometry on the Roche OMNI S Point-of-Care Analyzer",
abstract = "Jaundice is a common finding in healthy and diseased neonates. Because of early discharge, the risk of kernicterus is a re-emerging problem in the United States. Precise and accurate determination of plasma total bilirubin concentrations is the indispensable prerequisite for proper management of jaundiced infants. In this multicenter study, we investigated the analytical performance of the Roche OMNI S blood gas analyzer for measurement of total bilirubin from neonatal whole blood using a multiple-wavelength photometric method. The results were evaluated relative to simultaneously obtained results from routine clinical chemistry methods and one other point-of-care testing device. A total of 496 heparinized blood samples were drawn from newborns (≤39 days of age). An aliquot of the whole-blood sample was measured on Roche OMNI S and on the Radiometer ABL 735. Plasma was prepared from the remaining sample for laboratory analysis. Total bilirubin was measured on the LX20 (Beckman Coulter), Hitachi 912 and 717 (Roche Diagnostics), Dimension (Dade Behring), and Vitros 250 (Ortho Clinical Diagnostics). Plasma bilirubin concentrations covered the diagnostic relevant range up to 23.7 mg/dL. Overall, there was a good agreement between the bilirubin concentrations measured in whole blood on Roche OMNI S and Radiometer ABL 735 and between the comparison routine analyzers. Correlation coefficients were all above 0.94, and the slope of the regression lines ranged from 0.971 to 1.172. The mean biases ranged from -0.3 to 1.4 mg/dL, and the differences between comparison methods were less than those reported in proficiency testing. Direct spectrophotometric measurement of bilirubin in neonatal whole-blood samples gives results that compare well with those obtained using routine clinical chemistry methods. Its advantages are the very small volume of blood and the short turn-around time. Thus, the Roche OMNI S analyzer represents a suitable method for monitoring neonatal jaundice at the point of care.",
keywords = "analysis, bilirubin, determination, multiwavelength photometry, neonate, point-of-care testing, whole blood",
author = "Boris Rolinski and Anthony Okorodudu and Gerald Kost and Markus Roser and Jiaxi Wu and Ada Goerlach-Graw and Helmut Kuester",
year = "2004",
doi = "10.1097/01.poc.0000157097.59514.62",
language = "English (US)",
volume = "4",
pages = "3--8",
journal = "Plastic Surgical Nursing",
issn = "0741-5206",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Evaluation of Total Bilirubin Determination in Neonatal Whole-Blood Samples by Multiwavelength Photometry on the Roche OMNI S Point-of-Care Analyzer

AU - Rolinski, Boris

AU - Okorodudu, Anthony

AU - Kost, Gerald

AU - Roser, Markus

AU - Wu, Jiaxi

AU - Goerlach-Graw, Ada

AU - Kuester, Helmut

PY - 2004

Y1 - 2004

N2 - Jaundice is a common finding in healthy and diseased neonates. Because of early discharge, the risk of kernicterus is a re-emerging problem in the United States. Precise and accurate determination of plasma total bilirubin concentrations is the indispensable prerequisite for proper management of jaundiced infants. In this multicenter study, we investigated the analytical performance of the Roche OMNI S blood gas analyzer for measurement of total bilirubin from neonatal whole blood using a multiple-wavelength photometric method. The results were evaluated relative to simultaneously obtained results from routine clinical chemistry methods and one other point-of-care testing device. A total of 496 heparinized blood samples were drawn from newborns (≤39 days of age). An aliquot of the whole-blood sample was measured on Roche OMNI S and on the Radiometer ABL 735. Plasma was prepared from the remaining sample for laboratory analysis. Total bilirubin was measured on the LX20 (Beckman Coulter), Hitachi 912 and 717 (Roche Diagnostics), Dimension (Dade Behring), and Vitros 250 (Ortho Clinical Diagnostics). Plasma bilirubin concentrations covered the diagnostic relevant range up to 23.7 mg/dL. Overall, there was a good agreement between the bilirubin concentrations measured in whole blood on Roche OMNI S and Radiometer ABL 735 and between the comparison routine analyzers. Correlation coefficients were all above 0.94, and the slope of the regression lines ranged from 0.971 to 1.172. The mean biases ranged from -0.3 to 1.4 mg/dL, and the differences between comparison methods were less than those reported in proficiency testing. Direct spectrophotometric measurement of bilirubin in neonatal whole-blood samples gives results that compare well with those obtained using routine clinical chemistry methods. Its advantages are the very small volume of blood and the short turn-around time. Thus, the Roche OMNI S analyzer represents a suitable method for monitoring neonatal jaundice at the point of care.

AB - Jaundice is a common finding in healthy and diseased neonates. Because of early discharge, the risk of kernicterus is a re-emerging problem in the United States. Precise and accurate determination of plasma total bilirubin concentrations is the indispensable prerequisite for proper management of jaundiced infants. In this multicenter study, we investigated the analytical performance of the Roche OMNI S blood gas analyzer for measurement of total bilirubin from neonatal whole blood using a multiple-wavelength photometric method. The results were evaluated relative to simultaneously obtained results from routine clinical chemistry methods and one other point-of-care testing device. A total of 496 heparinized blood samples were drawn from newborns (≤39 days of age). An aliquot of the whole-blood sample was measured on Roche OMNI S and on the Radiometer ABL 735. Plasma was prepared from the remaining sample for laboratory analysis. Total bilirubin was measured on the LX20 (Beckman Coulter), Hitachi 912 and 717 (Roche Diagnostics), Dimension (Dade Behring), and Vitros 250 (Ortho Clinical Diagnostics). Plasma bilirubin concentrations covered the diagnostic relevant range up to 23.7 mg/dL. Overall, there was a good agreement between the bilirubin concentrations measured in whole blood on Roche OMNI S and Radiometer ABL 735 and between the comparison routine analyzers. Correlation coefficients were all above 0.94, and the slope of the regression lines ranged from 0.971 to 1.172. The mean biases ranged from -0.3 to 1.4 mg/dL, and the differences between comparison methods were less than those reported in proficiency testing. Direct spectrophotometric measurement of bilirubin in neonatal whole-blood samples gives results that compare well with those obtained using routine clinical chemistry methods. Its advantages are the very small volume of blood and the short turn-around time. Thus, the Roche OMNI S analyzer represents a suitable method for monitoring neonatal jaundice at the point of care.

KW - analysis

KW - bilirubin

KW - determination

KW - multiwavelength photometry

KW - neonate

KW - point-of-care testing

KW - whole blood

UR - http://www.scopus.com/inward/record.url?scp=33746633638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746633638&partnerID=8YFLogxK

U2 - 10.1097/01.poc.0000157097.59514.62

DO - 10.1097/01.poc.0000157097.59514.62

M3 - Article

AN - SCOPUS:33746633638

VL - 4

SP - 3

EP - 8

JO - Plastic Surgical Nursing

JF - Plastic Surgical Nursing

SN - 0741-5206

IS - 1

ER -